Skip to content

Study · Not a test of the peptide alone · 2000

3 results

[Efficiency in the dispensary care and surgical treatment of glaucoma patients].

Iunusova GD

Vestnik oftalmologii1 Jan 2000

PMID11055224 (opens in a new tab)PepBankPUB-11055224
Publisher pageAsk about this study
Jump to 3 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study3

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone3

In this study, Cerebrolysin was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Cerebrolysin.

  1. 01HumanNot a test of Cerebrolysin aloneCase report or seriesEfficacy outcome

    In advanced glaucoma patients, postoperative treatment with trental, Cerebrolysin and electric stimulation arrested the glaucomatous process.

    In plain wordsIn patients with advanced glaucoma, combined postoperative treatment including Cerebrolysin arrested glaucoma progression.

    Peptide
    Cerebrolysin
    Outcome
    Direction not reportedGlaucomatous process
    Study

    n: not reported in source

    Outcome group
    Vision and retina · Eye

    Source sentences

    Summary
    the glaucomatous process was arrested, visual acuity improved, and visual field extended.
    1 context sentence
    Summary · context
    In patients with developed and far-advanced glaucoma administered complex treatment after surgery, including retrobulbar injections of trental (0.5 ml, 10 injections per course), cerebrolysin (0.5 ml, 10 injections per course), and electric stimulation of the visual analyzer,

    In this study, Cerebrolysin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Cerebrolysin.

  2. 02HumanNot a test of Cerebrolysin aloneCase report or seriesEfficacy outcome

    In advanced glaucoma patients, postoperative treatment with trental, Cerebrolysin and electric stimulation improved visual acuity.

    In plain wordsIn patients with advanced glaucoma, combined postoperative treatment including Cerebrolysin improved visual acuity.

    Peptide
    Cerebrolysin
    Outcome
    IncreaseVisual acuity
    Study

    n: not reported in source

    Outcome group
    Vision and retina · Eye

    Source sentences

    Summary
    the glaucomatous process was arrested, visual acuity improved, and visual field extended.
    1 context sentence
    Summary · context
    In patients with developed and far-advanced glaucoma administered complex treatment after surgery, including retrobulbar injections of trental (0.5 ml, 10 injections per course), cerebrolysin (0.5 ml, 10 injections per course), and electric stimulation of the visual analyzer,

    In this study, Cerebrolysin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Cerebrolysin.

  3. 03HumanNot a test of Cerebrolysin aloneCase report or seriesEfficacy outcome

    In advanced glaucoma patients, postoperative treatment with trental, Cerebrolysin and electric stimulation extended the visual field.

    In plain wordsIn patients with advanced glaucoma, combined postoperative treatment including Cerebrolysin extended the visual field.

    Peptide
    Cerebrolysin
    Outcome
    IncreaseVisual field
    Study

    n: not reported in source

    Outcome group
    Vision and retina · Eye

    Source sentences

    Summary
    the glaucomatous process was arrested, visual acuity improved, and visual field extended.
    1 context sentence
    Summary · context
    In patients with developed and far-advanced glaucoma administered complex treatment after surgery, including retrobulbar injections of trental (0.5 ml, 10 injections per course), cerebrolysin (0.5 ml, 10 injections per course), and electric stimulation of the visual analyzer,

    In this study, Cerebrolysin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Cerebrolysin.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    14 Oct 2026, 05:02 UTC

    Study results updated

  2. Version 1

    14 Oct 2026, 01:46 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.